DE19739763A1 - Vitamin preparation for treating various diseases e.g. depression, itching and stroke - Google Patents

Vitamin preparation for treating various diseases e.g. depression, itching and stroke

Info

Publication number
DE19739763A1
DE19739763A1 DE1997139763 DE19739763A DE19739763A1 DE 19739763 A1 DE19739763 A1 DE 19739763A1 DE 1997139763 DE1997139763 DE 1997139763 DE 19739763 A DE19739763 A DE 19739763A DE 19739763 A1 DE19739763 A1 DE 19739763A1
Authority
DE
Germany
Prior art keywords
depression
itching
stroke
various diseases
treating various
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE1997139763
Other languages
German (de)
Inventor
Franz Uhl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to DE1997139763 priority Critical patent/DE19739763A1/en
Publication of DE19739763A1 publication Critical patent/DE19739763A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Vitamin B3 and niacin are used in high doses for the preparation of medicaments for the treatment of e.g. depression, symptoms of diseases and blood congestion form accidental injuries.

Description

Die Verwendung von Vitamin B3/Niacin in sehr hochdosierter Form, zur Herstellung von Medikamente, Arzneimittel, Heilmittel, Präparat und Mixtur, zur medizinischen Behandlung in globaler Sicht zur Lösung von körperlichen Blockaden, wie z. B.
The use of vitamin B3 / niacin in a very high dose form, for the manufacture of medicines, drugs, remedies, preparation and mixture, for medical treatment in a global perspective to solve physical blockages, such as. B.

  • a. Depressionena. depressions
  • b. Krankheitssymptomenb. Symptoms of illness
  • c. Veraltete Blutstauungen von Unfallverletzungen.c. Outdated congestion from accidental injuries.

Zu Punkt a,b,c, eine eigene Erkenntnis und Endeckung, entstand in Bezug in eigener schwerer Krankheitsgeschichte eines medizinischen Kunstfehlers, aus den ersten öligem Kontrastmittel-Versuchen, in Folge in langer Sicht als Geschädigter von starker gesundheitlicher Nervensystem-Beeinträchtigung durch Depressionen. Dessen Auflösung der Depressionen mit eigener Behandlung von sehr hochdosiertem Vitamin B3/Niacin, bis hin zu 5 g täglich, mit Einnahme mit sehr viel Flüssigkeit. With regard to points a, b, c, an own knowledge and discovery arose in relation in his own serious medical history of a medical malpractice, from the first oily contrast medium tests, in the long run as Damaged by severe nervous system impairment through depression. Its resolution of the depression with its own Treatment of very high-dose vitamin B3 / niacin, up to 5 g daily, with a lot of liquid.  

Die sehr hochdosierte Einnahme von Vitamin B3/Niacin hatte bis jetzt bei mir keine Nebenwirkungen zur Folge, sondern ein positives Erscheinungsbild, wie:
The very high-dose intake of vitamin B3 / niacin has so far not resulted in any side effects for me, but a positive appearance, such as:

  • 1. Juckreiz an den Körperstellen wo die Depressionen am stärksten waren und nach verschwinden des Juckreizes, waren die Depressionen an dessen Körperstellen langzeitlich verschwunden bzw. abnehmender Zustand.1. Itching on the parts of the body where the depression was most severe and after the itching went away, the depression was on it Body areas disappeared over time or decreased.
  • 2. Bedingt jahrelanger chronischer Durchfall mit Magenüberreizung, plötzlich ausgeheilt2. Conditional years of chronic diarrhea with stomach irritation, suddenly healed
  • 3. Ein alter Bluterguß der seit Jahren am linken unteren Ellenbogen sich zeigte war plötzlich verschwunden.3. An old bruise that had appeared on the lower left elbow for years was suddenly gone.
  • 4. Starke körperliche Verjüngung besonders im Gesicht. Abbau von schädlichen Körperfetten.4. Strong physical rejuvenation, especially on the face. Breakdown of harmful body fats.
  • 5. In weiterer Praxis, meine Mutter mit 73 Jahren hatte einen kleinen Gehirnschlag indem sie von da an in geistiger Verwirrung war und nach Einnahme von Vitamin B3/Niacin, war sie am nächsten Tag wieder ganz klar bei Verstand bis heute.5. In further practice, my mother at 73 years old had a small stroke by going from then on she was in mental confusion and after taking vitamin B3 / niacin, she was the next day again clearly up to the present day.

Erkenntnis für die Medizin aus meinem Behandlungsfall ergibt:Knowledge for medicine from my case of treatment results in:

Auflösung bzw. Entkrampfung bei sämtlichen Gehirnkrankheiten, wie z. B.:
Dissolution or relaxation in all brain diseases, such as B .:

  • 1. Nach Gehirnschlag, bzw. zur Vorbeugung.1. After a stroke or for prevention.
  • 2. Nach Gehirn gesteuerterm Herzinfarkt, bzw. zur Vorbeugung.2. Heart attack controlled by brain, or for prevention.
  • 3. Multiple Sklerose-Arten.3. Multiple sclerosis types.
  • 4. Epilepsie.4. Epilepsy.
  • 5. Alzheimer.5. Alzheimer's.
  • 6. Parkinson.6. Parkinson's.
  • 7. Nach Gehirnblutungen.7. After bleeding from the brain.
  • 8. Allgemeine Erschöpfungszustände.8. General states of exhaustion.
  • 9. Stottern.9. Stutter.
  • 10. Gehirnwiederbelebung wenn EEG-Kurven auf Null zeigen.10. Brain resuscitation when EEG curves show zero.

Auflösung bzw. Entkrampfung bei körperlichen Blockaden, wie z. B.:
Dissolution or relaxation in physical blockages, such as. B .:

  • 11. Blutblockaden-Auflösung z. B. bei Querschnittlähmungen mit örtlicher Behandlung.11. Blood blockage dissolving z. B. in paraplegia with local treatment.
  • 12. Körperliche Verjüngung, Abbau von schädlichen Körperfetten.12. Physical rejuvenation, reduction of harmful body fats.
  • 13. Organtrop, örtlicher Behandlung.13. Organtrop, topical treatment.
  • 14. Blockaden von Krebsgeschwulsten bleibt noch fraglich.14. Blockages of cancerous tumors remain questionable.

Claims (1)

Die Verwendung von Vitamin B3/Niacin in sehr hochdosierter Form, zur Herstellung von Medikamente, Arzneimittel, Heilmittel, Präparat und Mixtur, zur medizinischen Behandlung in globaler Sicht zur Lösung von körperlichen Blockaden, wie z. B.
  • a. Depressionen
  • b. Krankheitssymptomen
  • c. Veraltete Blutstauungen von Unfallverletzungen.
The use of vitamin B3 / niacin in a very high dose form, for the manufacture of medicines, drugs, remedies, preparation and mixture, for medical treatment in a global perspective to solve physical blockages, such as. B.
  • a. depressions
  • b. Symptoms of illness
  • c. Outdated congestion from accidental injuries.
DE1997139763 1997-09-10 1997-09-10 Vitamin preparation for treating various diseases e.g. depression, itching and stroke Withdrawn DE19739763A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE1997139763 DE19739763A1 (en) 1997-09-10 1997-09-10 Vitamin preparation for treating various diseases e.g. depression, itching and stroke

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1997139763 DE19739763A1 (en) 1997-09-10 1997-09-10 Vitamin preparation for treating various diseases e.g. depression, itching and stroke

Publications (1)

Publication Number Publication Date
DE19739763A1 true DE19739763A1 (en) 1999-09-23

Family

ID=7841889

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1997139763 Withdrawn DE19739763A1 (en) 1997-09-10 1997-09-10 Vitamin preparation for treating various diseases e.g. depression, itching and stroke

Country Status (1)

Country Link
DE (1) DE19739763A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005039546A3 (en) * 2003-10-03 2007-10-04 Veijlen N V Use of indoleacetic acid derivatives which increase the serum igf-1 level for the preparation of a therapeutical composition for treatment of various diseases
US8883233B2 (en) 2003-10-03 2014-11-11 Veijlen N.V. Animal feed composition

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005039546A3 (en) * 2003-10-03 2007-10-04 Veijlen N V Use of indoleacetic acid derivatives which increase the serum igf-1 level for the preparation of a therapeutical composition for treatment of various diseases
US8883233B2 (en) 2003-10-03 2014-11-11 Veijlen N.V. Animal feed composition
US9408405B2 (en) 2003-10-03 2016-08-09 Veijlen N.V. Use of compounds that are able to increase the serum IGF-1 level for the preparation of a therapeutical composition for treatment of various disease states associated with a reduced IGF-1 serum level in humans and animals
US10716778B2 (en) 2003-10-03 2020-07-21 Veijlen Use of compounds that are able to increase the serum IGF-1 level for the preparation of a therapeutical composition for treatment of various disease states associated with a reduced IGF-1 serum level in humans and animals

Similar Documents

Publication Publication Date Title
DE19737348C2 (en) Pharmaceutical composition containing clindamycin and clotrimazole
EP0037488B1 (en) Pharmaceutical composition for healing inflammatory and/or degenerative and/or atrophic mucous membranes
DE4214953A1 (en) Medicines to increase testosterone levels
AT397200B (en) USE OF SELENIUM METHIONINE IN THE PRODUCTION OF A MEDICINAL PRODUCT
DE19739763A1 (en) Vitamin preparation for treating various diseases e.g. depression, itching and stroke
DE1917283C3 (en) Manufacture of antimicrobial preparations
EP2796143B1 (en) Pharmaceutical homeopathic medication for reducing weight
WO2006095178A1 (en) Medicament and treatment for herpes simplex
EP2548564B1 (en) Pharmaceutical agent, nutrition for a patient and weight reduction method
DE19518836C2 (en) Medicines or medicines, in particular for the prevention and treatment of pressure ulcers
AT367292B (en) DEVICE IMPLANTABLE INTO THE BODY FOR CONSTANT DELIVERY OF AN ACTIVE SUBSTANCE
DE10247339A1 (en) Composition, useful in the treatment of psoriasis, comprises e.g., Gan Jiang (dried ginger), Dan Shen (Danshen root/red sage) and Jiang Xiang (rosewood heart wood)
AU2021103070A4 (en) A novel composition for the treatment of tuberculosis
DE2325072A1 (en) MEDICINAL PRODUCTS BASED ON LYSINE DERIVATIVES FOR COMBATING LEUCOPENIA
DE1947222A1 (en) Dosage for ionic therapy
DE1808173A1 (en) Calcium orotate preparations for therapeu- - tic use
GOULDMAN et al. Effects of a drug on the body odor of the chronically mentally ill
DE2144060C3 (en) Medicines with an anticonvulsant effect
Javitt ‘Cheno’Therapy for Gallstones: Where the Cooperative Study Now Stands
Gerush et al. Investigation of the hepatoprotective properties of “Phytovenol” capsules on the model of medicamentous hepatitis in rats
JPH04178331A (en) New therapeutic agent for athlete's foot
Seton et al. Aesculapius in Fife: A Study of the Early Eighteenth Century
DE2351108A1 (en) Folic acid in treatment of gastric and duodenal ulcers - with high healing rate
DE4435352A1 (en) Medicines for the treatment of AIDS
Neiger Über die Wirkung des Zytostatikums SPG und SPI bei lokaler Applikation im ORL-Bereich (mit Farbtafel I)

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee